Head-to-head · Value Score
yourEra vs Hims & Hers
Two GLP-1 deals, scored on the same six factors. yourEra lands a Value Score of 84, Hims & Hers a 80. Here's who gives you the honest lower price — and where each one bites back.
yourEra
#25 · Grade B+ · Good Value
Est. first month
$199/mo
Save ~85% vs brand-nameHims & Hers
#68 · Grade B · Good Value
Est. first month
$199/mo
Save ~85% vs brand-nameFDA warning letter. The FDA issued Hims & Hers Health, Inc. dba Hims a warning letter in September 2025. Check it on the FDA database.
Get this deal Full Hims & Hers review →The verdict
yourEra takes it on Value Score, 84 to 80 — an est. $199/mo first month, with no teaser step-up baked in. Hims & Hers isn't out of it: People who want a familiar consumer brand and a visible semaglutide price.
Deal-by-deal
The numbers that decide it. Green ✓ marks the stronger side on each line.
| Deal | yourEra | Hims & Hers |
|---|---|---|
| Value Score | 84 (B+) | 80 (B) |
| Est. first month | $199/mo | $199/mo |
| Save vs brand-name | ~85% | ~85% |
| Semaglutide | $199/mo | $199/mo |
| Tirzepatide | $299/mo | Not disclosed |
| Both molecules | Yes | No |
| Pricing | Flat — no step-up | Flat — no step-up |
| Coverage | All 50 states | All 50 states |
Factor by factor
The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.
yourEra
A transparent, publicly priced GLP-1 program — both molecules at $199/$299 with no hidden quiz-wall — that's honest and mid-market rather than rock-bottom.
Why it's a deal
- Publishes prices openly on the site — $199 sema / $299 tirz — while many compounders hide pricing behind an intake quiz
- Both compounded semaglutide and tirzepatide, plus a broader menu (NAD+, microdosing, optional coaching/nutritionist/lab bundle)
- Markets a 50-state licensed-clinician network; no insurance required and HSA/FSA accepted
The fine print
- Mid-market pricing — $199/$299 sits above the cheapest compounders (~$99–$150), so it's not the value leader
- Compounded only and not FDA-approved — not equivalent to brand Wegovy/Ozempic/Zepbound, and availability can tighten as brand shortages resolve
- Injectable only — no FDA-approved brand-name lane and no oral option
- Thin independent footprint; the 50-state and efficacy claims are self-reported
Hims & Hers
A familiar, app-first brand with an up-front $199 semaglutide price and nationwide reach.
Why it's a deal
- Up-front $199 semaglutide
- Available in all 50 states
- Slick app experience and strong brand trust
The fine print
- Tirzepatide pricing not consistently disclosed
- Compounded supply has drawn industry-wide regulatory scrutiny
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.
Neither one the right fit? Every program that outscores yourEra is ranked on the yourEra alternatives ranking, and the same list for the other side is on alternatives to Hims & Hers.
More head-to-heads
Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.